Guadalupe
Hayes-Mota
Advocate for patients to have access to medicines and health services globally
Healthcare, Biotech, & Public Service Leader:
Story
Born in Mexico with a rare and debilitating bleeding disorder, Guadalupe nearly died at twelve because of limited access to medicines. One night, his appendix burst, and he began bleeding internally, requiring emergency surgery. In search of better medication to stop the bleeding, Guadalupe was rushed to a hospital eight hours away. He bled so severely during the surgery that his heart stopped beating, and the doctors declared him clinically dead. But against all odds, Guadalupe survived.
After his recovery, his family and he migrated to the U.S., searching for better healthcare for him. The transition was difficult: his parents arrived in California with little money or education, and Guadalupe spoke no English. Navigating the health care system as an immigrant and not knowing the language was a challenge. Accessing treatment and services for his disease was practically impossible at first. The nearest specialist was one hr and a half away. Thankfully, he gained access to care and treatment with help from the Hemophilia Association chapter in the area. Driven by his experiences, Guadalupe made it his mission to fight for justice and equity in the healthcare system.
Guadalupe Hayes-Mota
Video: Guadalupe speaks about growing up with hemophilia in Mexico without medicines.
Experience
Mission..............................
Guadalupe's mission is to build a world where no one is without the medical treatment they need to survive and thrive. Justice and equity are his core values. Both arise from his own experience as a person who has, in many ways, lived on the margins. He seeks to serve as a catalyst for change and innovation for biopharmaceuticals, hospitals, clinics, government, and non-profits.
Professional Experience.........
Guided by his comprehensive healthcare experience and the better to achieve his life goal of expanding access to medical treatment globally, he founded and serve as CEO of Healr Solutions, a company engineering technology to solve the most pressing issues in supply chains in the biopharmaceutical industry.
As a provider of services and medicines, Guadalupe led the global departments at Fortune 500 biopharmaceutical firms (Ultragenyx, Biogen, Amgen, and GSK) in supply chain, manufacturing, sourcing, packaging, logistics, and distribution of medicines to 113 countries, supplying millions of people with treatments. He ran the most extensive free healthcare system in the United States (UCLA Health), providing 30,000 underserved patients free healthcare and medicine. Guadalupe also assisted in developing and implementing the Affordable Care Act (Obama Care) that provided healthcare access to 20 million people in the United States (RAND Corporation). In addition to his corporate roles, he researched the development of new medications at MIT with Moderna's founder, Professor Bob Langer.
As a healthcare expert, Guadalupe has been featured in Forbes, Business Insider, STAT News, MIT Technology Review, Boston Globe, Los Angeles Business Journal, and Boston Business Journal. He has spoken at events and conferences at MIT, Harvard, and UPenn, and has testified before the United States House of Representatives and Senate.
Public Service & Boards.........
Governor Charlie Baker appointed him to the Massachusetts Rare Disease Advisory Council to provide direction for the Governor, the Legislature, and the Department of Public Health on addressing rare disease policy and actions in the State of Massachusetts.
The MIT PKG Public Service Center named him a Practioner-in-Residence & Lecturer, teaching MIT students through seminars, lectures, and mentorship about business, engineering, and public service. MIT and the MIT Alumni Association awarded him the prestigious Margaret L.A. MacVicar Award in 2021.
Guadalupe re-founded and served as President of the MIT LBGT+ Alumni Association Board. He is on the board of directors of Save One Life, MIT Alumni Association, and serves as Treasurer of Fenway Health. Guadalupe is an Advisory Board Member for Sanofi, a Fortune 500 biopharmaceutical company.
Education............................
Guadalupe received a BS in Chemistry, an MS in Engineering Systems, and an MBA from the Massachusetts Institute of Technology (MIT). He obtained a Master of Public Policy from Georgetown University, and he is pursuing a Mid-Career Master of Public Administration in American Politics at Harvard University.
Honors................................
-
6 Powerful LGBTQ+ Executives - Business Insider
-
Forbes Business Council Member - Forbes
-
US Young Engineering Leader - National Academy of Engineering
-
John F. Kennedy Fellowship - Harvard University
-
Notable Alum - MIT
-
100 Top Leaders in the Life Science Industry - PharmaVoice
-
40 under 40 - Boston Business Journal
-
Healthcare Executive of the Year - Los Angeles Business Journal
Public Service
Fenway Health
Treasurer,
Board of Directors
Advocates for and delivers innovative, equitable, accessible health care, supportive services, and transformative research and education. Focuses on LGBTQIA+, BIPOC, and other underserved groups to enable local, national, and global neighbors to flourish.
Rare Disease Advisory Council
Council Member
Appointed by Governor Baker to provide advice to the Governor, Senate, House of Representatives, and Department of Public Health on how to address rare disease policy and actions in the State of Massachusetts
Save One Life
Board of Directors
Empowers individuals and families affected by bleeding disorders in developing countries through direct financial assistance and access to medical treatment.
MIT Alumni Association
Board of Directors
Engage and inspire the global MIT community to make a better world. The MIT Alumni Association's mission is to further the well-being of the Institute and its graduates by increasing the interest of members in the school and in each other
PRESS
Press
Speaking Engagements
Webinar (PharmaVOICE) Guadalupe discusses how to lead worldwide teams in biotech.
Podcast (McSquare Health Podcast): COVID-19's Effects on Drug Discovery and Delivery.
.png)
Webinar (MIT Alumni Association): Connecting Communities - A Conversation on Race, LBGTQ+ Identity and STEM.
Presentation (Biomanufacturing and Cell and Gene Therapy Strategy Meeting):Internet of Things (IIoT) insights and knowledge to minimize waste within manufacturing systems.
Webinar (MIT Alumni Association): Career Paths chosen by LBGTQ+ leaders. Guadalupe explores how being LBGTQ+ influences career paths.
Presentation (MIT Tech Reunions): Guadalupe reflects on the impact he is having in global and local communities through board of directors service and governmental appointments.
Panel (WEGO Health): WEGO Health sat down with top rare disease patient leaders to discuss the importance of resilience, managing your own care, story sharing, and raising awareness to support the rare disease community.
Panel (MIT Sloan Healthcare Conference): Guadalupe covers the major challenges faced during the rapid scale-up of research, manufacturing, and distribution efforts during the Covid19 pandemic.
Podcast : From Mexico to MIT. Guadalupe talks about his struggles with hemophilia in Mexico, the shock of being an immigrant in the United States, going to MIT, learning and finding purpose.
Keynote Presentation (Clinical Trials Summit): Managing Clinical Global Supply Chains during COVID-19 times.
Webinar (New York City Hemophilia Chapter and New England Hemophilia Association): Guadalupe explores, in Spanish, advocacy in the Latino community and also about his life as a hemophiliac.
Presentation (Temperature Control & Logistics Summit): Embracing the next generation of pharma and biotech supply chains.
